Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

NCR1

  • Official Full Name

    natural cytotoxicity triggering receptor 1

  • Overview

    Natural cytotoxicity triggering receptor 1 is a protein that in humans is encoded by the NCR1 gene. NCR1 has also been designated as CD335 (cluster of differentiation 335).
  • Synonyms

    NCR1; natural cytotoxicity triggering receptor 1; LY94, lymphocyte antigen 94 (mouse) homolog (activating NK receptor; NK p46); CD335; NK p46; NKP46; FLJ99094; hNKp46; Ly94; Lymphocyte antigen 94; Lymphocyte antigen 94 homolog (activating NK receptor; Lymphocyte antigen 94 homolog; Natural killer cell p46-related protein; NCT1; NCTR1_HUMAN; NK cell activating receptor; NK cell-activating receptor; NK-p46; lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46);

  • Recombinant Proteins
  • Protein Pre-coupled Magnetic Beads
  • Cell & Tissue Lysates
  • Cynomolgus
  • Cynomolgus Monkey
  • Homo sapiens (Human)
  • Human
  • Mouse
  • Rat
  • Rhesus Macaque
  • Rhesus monkey
  • E.coli
  • E.coli expression system
  • HEK293
  • HEK293T
  • Human Cell
  • Mammalian Cell
  • Mammalian cells
  • C
  • Fc
  • hFc
  • Fc Chimera
  • Avi
  • hIgG1
  • hIgG4
  • His
  • His (Fc)
  • His|T7
  • Flag
  • human|IgG1|Fc
  • lFc
  • Myc
  • DDK
  • Myc|DDK
  • N/A
  • T7|His
Species Cat.# Product name Source (Host) Tag Protein Length Price
Human NCR1-342H Active Recombinant Human NCR1, Fc Chimera Mammalian cells Fc Chimera
Human NCR1-0525H Active Recombinant Human NCR1 protein, lFc-tagged HEK293 lFc Gln22-Asn254
Human NCR1-27989TH Recombinant Human NCR1 E.coli N/A
Human NCR1-166H Recombinant Human Natural Cytotoxicity Triggering Receptor 1 E.coli N/A
Human NCR1-87H Recombinant Human NCR1 protein, T7/His-tagged E.coli T7/His
Human NCR1-472H Recombinant Human NCR1 Protein, MYC/DDK-tagged HEK293 Myc/DDK
Human NCR1-897H Recombinant Human NCR1 protein, His-tagged HEK293 His It contains Gln 22 - Asn 254.
Human NCR1-5339H Recombinant Human NCR1 Protein (Gln22-Asn254), C-Fc tagged Mammalian cells C-Fc Gln22-Asn254
Human NCR1-0519H Active Recombinant Human NCR1 protein, His-tagged HEK293 His Gln22-Arg258
Human NCR1-1847H Active Recombinant Human NCR1 protein, His-tagged, Biotinylated HEK293 His Gln 22 - Asn 254
Human NCR1-5647H Recombinant Human NCR1 Protein, Myc/DDK-tagged, C13 and N15-labeled HEK293T Myc/DDK
Human NCR1-322H Recombinant Human NCR1 protein, Fc-tagged HEK293 human/IgG1/Fc 233
Human NCR1-0526H Active Recombinant Human NCR1 protein, Fc-tagged HEK293 Fc Gln22-Asn254
Human NCR1-400H Recombinant Human NCR1 Protein, Fc-tagged HEK293 Fc 304
Human NCR1-204H Recombinant Human NCR1 Protein, His (Fc)-Avi-tagged HEK293 His (Fc)-Avi
Human NCR1-5338H Recombinant Human NCR1 Protein (Met1-Asn254), C-Fc tagged Mammalian cells C-Fc Met1-Asn254
Human NCR1-204H-B Recombinant Human NCR1 Protein Pre-coupled Magnetic Beads HEK293
Human NCR1-0524H Active Recombinant Human NCR1 protein, Fc-Avi-tagged, Biotinylated HEK293 Fc-Avi Gln22-Asn254
Mouse NCR1-10489M Active Recombinant Mouse NCR1 protein, His-tagged HEK293 His Met1-Asn255
Mouse Ncr1-1813M Recombinant Mouse Ncr1 protein, His & T7-tagged E.coli His/T7 Gln17~Thr211 (Accession # Q8C567)
Mouse NCR1-0520M Recombinant Mouse NCR1 protein, His-Avi-tagged, Biotinylated HEK293 His-Avi Glu22-Asn255
Mouse Ncr1-4317M Recombinant Mouse Ncr1 Protein, Myc/DDK-tagged HEK293T Myc/DDK
Rat Ncr1-8798R Recombinant Rat Ncr1 protein(Met1-Asn255), hFc-tagged HEK293 C-hFc Met1-Asn255
Rat NCR1-3924R Recombinant Rat NCR1 Protein Mammalian Cell His
Rat Ncr1-1814R Recombinant Rat Ncr1 protein, His & T7-tagged E.coli His/T7 Gln17~Arg258 (Accession # Q9Z0H5)
Rat NCR1-1244RCL Recombinant Rat NCR1 cell lysate Human Cell N/A
Rat NCR1-3582R-B Recombinant Rat NCR1 Protein Pre-coupled Magnetic Beads HEK293
Rat NCR1-3582R Recombinant Rat NCR1 Protein, His (Fc)-Avi-tagged HEK293 His (Fc)-Avi
Rhesus monkey NCR1-1755R Recombinant Rhesus Monkey NCR1 Protein HEK293 N/A
Rhesus monkey NCR1-1756R Recombinant Rhesus Monkey NCR1 Protein, hIgG1-tagged HEK293 hIgG1
Rhesus monkey NCR1-1757R Recombinant Rhesus Monkey NCR1 Protein, hIgG4-tagged HEK293 hIgG4
Cynomolgus NCR1-0521C Active Recombinant Cynomolgus NCR1 protein, lFc-tagged HEK293 lFc Pro22-Arg257
Cynomolgus NCR1-0522C Active Recombinant Cynomolgus NCR1 protein, His-Avi-tagged, Biotinylated HEK293 His-Avi Pro22-Arg257
Cynomolgus NCR1-0523C Active Recombinant Cynomolgus NCR1 protein, His-tagged HEK293 His Pro22-Arg257
Cynomolgus NCR1-02C Recombinant Cynomolgus NCR1 Protein, His-Flag-Tagged E.coli His-Flag
Cynomolgus Monkey NCR1-729C Recombinant Cynomolgus NCR1 Protein, His-tagged Mammalian Cell His
Cynomolgus Monkey NCR1-473C Recombinant Cynomolgus Monkey NCR1 Protein, His (Fc)-Avi-tagged HEK293 His (Fc)-Avi
Cynomolgus Monkey NCR1-473C-B Recombinant Cynomolgus Monkey NCR1 Protein Pre-coupled Magnetic Beads HEK293
Homo sapiens (Human) RFL7817HF Recombinant Full Length Human Natural Cytotoxicity Triggering Receptor 1(Ncr1) Protein, His-Tagged E.coli expression system His Full Length of Mature Protein (22-304)
Rhesus Macaque NCR1-2960R Recombinant Rhesus monkey NCR1 Protein, His-tagged Mammalian Cell His
Rhesus Macaque NCR1-2779R-B Recombinant Rhesus Macaque NCR1 Protein Pre-coupled Magnetic Beads HEK293
Rhesus Macaque NCR1-2779R Recombinant Rhesus Macaque NCR1 Protein, His (Fc)-Avi-tagged HEK293 His (Fc)-Avi
  • Background
  • Quality Guarantee
  • Case Study
  • Involved Pathway
  • Protein Function
  • Interacting Protein
  • NCR1 Related Articles
  • NCR1 Related Research Area
NCR1-9.jpg

Fig1. Overview of individual NCR domain structures. NKp46 (yellow) has two Ig-like domains. (Alexander David Barrow, 2019)

What is NCR1 protein?

NCR1 (natural cytotoxicity triggering receptor 1) gene is a protein coding gene which situated on the long arm of chromosome 19 at locus 19q13. NCR1 is a protein that is mainly expressed on natural killer (NK) cells. NK cells are part of the immune system and are essential for recognizing and killing infected or mutated cells, such as cancer cells. NCR1 is a transmembrane protein whose extracellular portion contains multiple immunoglobulin-like domains. The NCR1 protein is consisted of 304 amino acids and its molecular mass is approximately 34.5 kDa.

What is the function of NCR1 protein?

NCR1 activates NK cells by recognizing their ligands, such as certain molecules expressed on the cell surface, triggering an immune response against infectious pathogens, tumor cells, and damaged normal cells. The function of NCR1 is involved in promoting the secretion of cytotoxins from NK cells, such as perforin and granzidase, and producing multiple cytokines, such as interferon-gamma (IFN-γ), which enhances the immune response and is involved in regulating immune surveillance and anti-tumor response.

NCR1 Related Signaling Pathway

The signaling pathway involved in NCR1 is mainly involved in cell recognition and clearance, especially for virus-infected cells and certain tumor cells. When NCR1 binds to its ligand, it activates downstream signaling pathways such as the PI3K/Akt, MAPK/ERK, and NF-κB signaling pathways. Activation of these pathways further promotes degranulation of NK cells, releasing cytotoxins such as perforin and granzidase, leading to apoptosis of target cells. In addition, NCR1 can also work synergistically with other NK cell receptors, such as CD16 and NKG2D, to enhance the cytotoxic effects of NK cells.

NCR1 Related Diseases

Mutations in the NCR1 gene are associated with a variety of diseases, including: Inherited NCR1 deficiency, a rare autosomal dominant genetic disorder in which patients are susceptible to infections, autoimmune diseases, and malignancies due to abnormalities in NK cell function caused by mutations in the NCR1 gene. Other autoimmune diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and multiple sclerosis (MS) have been associated.

Bioapplications of NCR1

In recent years, this protein has become the focus of cancer immunotherapy and drug development. Researchers are exploring the use of NCR1 agonists or its signaling pathway modulators to enhance the activity of NK cells, thereby providing new strategies for cancer treatment. At the same time, antibodies against NCR1 are also being studied for targeted therapies to improve the selective killing effect of tumor cells.

High Purity

High Bioactivity

NCR1-2.jpg

Fig2. Activity Data. (NCR1-897H)

Case study 1: Chiyuki Ueshima, 2015

NKp46 (natural cytotoxic receptor 1/CD335) is expressed on natural killer cells and Th2-type innate lymphocytes. However, NKp46 expression in human mast cells has not yet been reported. Here, the researchers explored the expression of, and possible role played by, NKp46 in such cells. NKp46 protein was expressed in human mast cells in urticaria pigmentosa principally of the tryptase-positive/chymase-negative type (MCT), but not in human non-neoplastic skin mast cells of the tryptase-positive/chymase-positive (MCTC) type. NKp46 expression was also evident in the human neoplastic mast cell line HMC1.2. NKp46 knockdown changed the phenotype of this cell line from MCT to MCTC and downregulated GrB production, but did not influence IL-22 production. An agonistic anti-NKp46 antibody upregulated production of GrB and IL-22, but did not change the MCT-like phenotype of HMC1.2 cells. NKp46 was thus involved in the production of serine proteases and IL-22 in human mast cells.

NCR1-3.jpg

Fig1. Flow cytometric analysis showed NKp46 protein expression in the human cultured neoplastic mast cell line HMC1.2.

NCR1-4.jpg
Fig2. GrB production. ELISA revealed that NKp46 knockdown reduced GrB production in the presence of an agonistic anti-NKp46 Ab for 16 h induced GrB production in HMC1.2 cells.

Case study 2: Pascal F Durrenberger, 2012

Pathogenic or regulatory effects of natural killer (NK) cells are implicated in many autoimmune diseases, but evidence in multiple sclerosis (MS) and its murine models remains equivocal. In an effort to illuminate this, the researchers have here analysed expression of the prototypic NK cell marker, NCR1 (natural cytotoxicity triggering receptor; NKp46; CD335), an activating receptor expressed by virtually all NK cells and therefore considered a pan-marker for NK cells. In this study, the researchers investigated whether there were differences in NCR1+ cells in the peripheral blood of MS patients and whether NCR1+ cells are present in white matter lesions.

NCR1 transcripts were increased more than 5 times in active disease lesions. However when they performed immunohistochemical staining of this tissue, few NCR1+ NK cells were identified. Rather, the major part of NCR1 expression was localised to astrocytes, and was considerably more pronounced in MS patients than controls. In order to further validate de novo expression of NCR1 in astrocytes, they used an in vitro staining of the human astrocytoma U251 cell line grown to model whether cell stress could be associated with expression of NCR1. They found up-regulation of NCR1 expression in U251 cells at both the mRNA and protein levels.

NCR1-5.jpg

Fig3. Immunoreactivity was quantified and a significant increase (p = 0.0003) in WML (4.945 ± 1.174) compared to controls (0.801 ± 0.27) was found when conducting a Mann Whitney test.

NCR1-6.jpg
Fig4. Semi-quantitative analysis of NCR1 expression showed a 43% increase in NCR1 expression after 3 days of culture.
NCR1-7.jpg

Fig1. NKp46 has an extracellular portion characterized by two Ig-C2 like domains. (R Biassoni, 2003)

NCR1-8.jpg

Fig2. Expression of the NCRs and their Ligands. NKp30 and NKp46 are expressed by resting (pink) as well as activated (orange) NK cells. (Alexander David Barrow, 2019)

NCR1 involved in several pathways and played different roles in them. We selected most pathways NCR1 participated on our site, such as Natural killer cell mediated cytotoxicity, which may be useful for your reference. Also, other proteins which involved in the same pathway with NCR1 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.

Pathway Name Pathway Related Protein
Natural killer cell mediated cytotoxicityHLA-A;ULBP3;FAS;HLA-G;Raet1c;Fasl;ITGB2;GZMB;IFNG

NCR1 has several biochemical functions, for example, receptor signaling protein activity. Some of the functions are cooperated with other proteins, some of the functions could acted by NCR1 itself. We selected most functions NCR1 had, and list some proteins which have the same functions with NCR1. You can find most of the proteins on our site.

Function Related Protein
receptor signaling protein activityRGS14;DOK1;DOK4;ARF1;CD3E;NSMAF;PDCL;RGS14A;RAF1A

NCR1 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with NCR1 here. Most of them are supplied by our site. Hope this information will be useful for your research of NCR1.

Grondahl-Rosado, C; Bonsdorff, TB; et al. NCR1(+) cells in dogs show phenotypic characteristics of natural killer cells. VETERINARY RESEARCH COMMUNICATIONS 39:19-30(2015).
Olsen, L; Boysen, P; et al. Characterization of NCR1+cells residing in lymphoid tissues in the gut of lambs indicates that the majority are NK cells. VETERINARY RESEARCH 44:-(2013).
  • Q&As
  • Reviews

Q&As (6)

Ask a question
What is the significance of the expression level of NCR1 protein in cancer immunotherapy? 11/13/2022

In some cancer immunotherapies, the expression level of NCR1 protein may affect the efficacy of the treatment. High levels of NCR1 expression may predict a better prognosis.

What is the significance of gene knockout technology to inhibit NCR1 expression in the treatment of autoimmune diseases? 06/02/2022

Inhibition of NCR1 expression by gene knockout technology can alleviate the symptoms of autoimmune diseases and provide new ideas and methods for the treatment of autoimmune diseases.

Is it possible to regulate the expression level of NCR1 protein through pharmacological intervention? 03/22/2022

There are currently no drugs that directly target the NCR1 protein, but there are some drugs that can affect the activity of the immune system and thus indirectly affect the expression level of the NCR1 protein.

Are there polymorphisms in the NCR1 gene and are they involved in the development of certain diseases? 01/23/2021

Yes, there are polymorphisms in the NCR1 gene, some of which may increase an individual's susceptibility to certain diseases such as inflammatory diseases and autoimmune diseases.

Are there antibodies or drugs against the NCR1 protein? 11/13/2020

There are currently no specific antibodies or drugs against the NCR1 protein, but there are some studies that are exploring the development of therapies against the NCR1 protein.

How can the function and mechanism of NCR1 protein be studied? 12/05/2019

The function and mechanism of action of NCR1 protein can be studied by gene knockout or knockdown techniques. In addition, techniques such as protein spectroscopy can be used to identify proteins that interact with NCR1 proteins and their sites of action.

Customer Reviews (3)

Write a review
Reviews
09/28/2022

    In drug screening experiments, it was found that it had good selectivity for specific disease-related targets.

    03/28/2022

      It has been observed in cell culture experiment that it can promote the growth and proliferation of cells.

      03/04/2021

        It has a wide range of applications and can be used in various biological experiments.

        Ask a Question for All NCR1 Products

        Required fields are marked with *

        My Review for All NCR1 Products

        Required fields are marked with *

        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends